Cytogenetic characterization of the malignant primitive neuroectodermal SK-PN-DW tumor cell line

Na Du1,2, Wanguo Bao1, Kaiyu Zhang1

  • 1Department of Infectious Diseases, the First Hospital of Jilin University, 71 Xinmin Street, Changchun, Jilin, 130021, People's Republic of China.

BMC Cancer
|May 4, 2019
PubMed
Abstract

Insights

This study characterized the SK-PN-DW cell line, revealing significant chromosomal alterations including losses and translocations. These findings provide a crucial cytogenetic profile for future research on primitive neuroectodermal tumors.

Area of Science:

  • Cytogenetics
  • Cancer Cell Line Characterization
  • Genomic Instability

Background:

  • The SK-PN-DW cell line, established in 1979, is a widely used in vitro model for malignant primitive neuroectodermal tumor (PNET) research.
  • However, a comprehensive understanding of its cytogenetic profile has been lacking, hindering precise interpretation of experimental results.

Purpose of the Study:

  • To perform a detailed cytogenetic characterization of the SK-PN-DW cell line.
  • To identify and document all numerical and structural chromosomal abnormalities present in this cell line.

Main Methods:

  • Routine G-banded karyotype analysis to assess numerical and gross structural changes.
  • Oligonucleotide array comparative genomic hybridization (aCGH) for high-resolution detection of copy number variations and precise breakpoint mapping.
  • Fluorescence in situ hybridization (FISH) to confirm specific chromosomal rearrangements.

Main Results:

  • Karyotype analysis revealed aneuploidy (36–41 chromosomes) with consistent loss of chromosomes Y, 11, 13, and 18, and variable loss of chromosome 10.
  • Identified structural abnormalities include unbalanced translocations (chr1/7, chr11/22), whole arm translocations (chr16/17), and potential rearrangements on chr18.
  • aCGH elucidated genomic-wide imbalances and the origin of double minutes, while FISH confirmed key findings.

Conclusions:

  • This study provides a comprehensive cytogenetic profile of the SK-PN-DW cell line, essential for its accurate use in PNET research.
  • The detailed characterization serves as a valuable public resource, enhancing the reliability and comparability of future studies utilizing this cell line.
  • Highlights the utility of integrated cytogenetic techniques for thorough cell line characterization.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.7K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.9K